Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Assay Kits  >  ELISA Kits  >>  SensoLyte® Anti-Mouse MOG (1-125) IgG Quantitative ELISA Kit

Product Name SensoLyte® Anti - Mouse MOG (1 - 125) IgG Quantitative ELISA Kit
Size 1 kit
Catalog # 55156
US$ $435
Description

Mouse MOG recombinant protein (1-125) [Cat# 55150] is able to induce autoantibody production and relapsing-remitting neurological disease causing extensive plaque-like demyelination. Autoantibody response to mouse MOG (1-125) has been observed in induced experimental autoimmune encephalomyelitis (EAE) in C57/BL6, 129/Sv, B6, and SJL mice.

The SensoLyte® Anti-Mouse MOG (1-125) IgG Quantitative ELISA Kit provides a convenient quantitative assay for anti-mouse MOG (1-125) autoantibody. This colorimetric assay is useful for determining the amount of anti-mouse MOG (1-125) antibody, and can help provide information on the role it plays in the development and treatment of EAE, an animal model for multiple sclerosis pathogenesis.

The kit contains:

• Pre-coated and pre-blocked 96-well strip plate
• Standard for calibration
• A detailed protocol
Kit Size: 80 assays


RELATED PRODUCTS:
SensoLyte® Anti - Human MOG (1 - 125) Mouse IgG Specific ELISA Kit
SensoLyte® Anti - Human MOG (1 - 125) Rat IgG Specific ELISA Kit
SensoLyte® Anti - Human MOG (1 - 125) Human IgG Specific ELISA Kit
SensoLyte® Anti - Rat MOG (1 - 125) IgG Quantitative ELISA Kit
SensoLyte® Anti – MOG (35 - 55) IgG Quantitative ELISA Kit (mouse/rat)
Recombinant MOG (1-125) Proteins - mouse, rat & human
Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Storage 4°C
Product Citations Molnarfi, N. et al. (2013). MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med 210, 2921. doi: 10.1084/jem.20130699.
Summers de Luca, L. et al. (2010). Substrain Differences Reveal Novel Disease-Modifying Gene Candidates That Alter the Clinical Course of a Rodent Model of Multiple Sclerosis. J Immunol 184, 3174.
     
  < Back